Table 1_Machine learning-based differentiation of lung squamous cell carcinoma and adenocarcinoma using clinical-semantic and radiomic features.docx

Table 1_Machine learning-based differentiation of lung squamous cell carcinoma and adenocarcinoma using clinical-semantic and radiomic features.docx

Purpose<p>To evaluate and compare the predictive performance of machine learning methods using clinical-semantic, radiomic, and combined features in distinguishing squamous cell carcinoma (SCC) from adenocarcinoma (ADC) in non-small cell lung cancer (NSCLC).</p>Methods<p>A total of...

Descrizione completa

Salvato in:

Dettagli Bibliografici
Autore principale:	Yanju Li (9697993) (author)
Altri autori:	Xiaomeng Yang (702951) (author), Yingjin Zhang (20532682) (author), Jing Liang (32441) (author), Jiaxin Liu (833821) (author), Xinru Zheng (16801562) (author), Jing Wang (6206297) (author), Zhaoxiang Ye (4468483) (author)
Pubblicazione:	2025
Soggetti:	Oncology and Carcinogenesis not elsewhere classified squamous cell carcinoma adenocarcinoma radiomics machine learning computed tomography
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Table 2_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
di: Rui Wang (52434)
Pubblicazione: (2025)

Table 3_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
di: Rui Wang (52434)
Pubblicazione: (2025)

Table 1_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.xlsx
di: Rui Wang (52434)
Pubblicazione: (2025)

Additional file 14 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
di: Xu Han (141301)
Pubblicazione: (2025)

Additional file 13 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
di: Xu Han (141301)
Pubblicazione: (2025)

Additional file 12 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
di: Xu Han (141301)
Pubblicazione: (2025)

Additional file 11 of Development of a cancer metastasis-associated risk model via multi-machine-learning algorithms for prognostic risk evaluation and clinical application in oral squamous cell carcinoma
di: Xu Han (141301)
Pubblicazione: (2025)

Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
di: Hailong Pang (12841991)
Pubblicazione: (2025)

Data Sheet 2_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
di: Hailong Pang (12841991)
Pubblicazione: (2025)

Data Sheet 1_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
di: Hailong Pang (12841991)
Pubblicazione: (2025)

Table 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.docx
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Table 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Table 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 9_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 10_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 11_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 7_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 8_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 5_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 6_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 4_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Image 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
di: Jichang Liu (1263291)
Pubblicazione: (2025)

Comparative transcriptome atlas as an assistive modality for complex classification of rare kidney cancers
di: Hasashi Hasumi (21471185)
Pubblicazione: (2025)

Image 9_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
di: Xiangjun Wang (2522917)
Pubblicazione: (2025)

Image 8_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
di: Xiangjun Wang (2522917)
Pubblicazione: (2025)

Image 6_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
di: Xiangjun Wang (2522917)
Pubblicazione: (2025)

Image 7_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
di: Xiangjun Wang (2522917)
Pubblicazione: (2025)

Image 4_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
di: Xiangjun Wang (2522917)
Pubblicazione: (2025)

Image 5_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
di: Xiangjun Wang (2522917)
Pubblicazione: (2025)

Image 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
di: Xiangjun Wang (2522917)
Pubblicazione: (2025)

Image 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
di: Xiangjun Wang (2522917)
Pubblicazione: (2025)

Image 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
di: Xiangjun Wang (2522917)
Pubblicazione: (2025)

Table 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
di: Xiangjun Wang (2522917)
Pubblicazione: (2025)

Table 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
di: Xiangjun Wang (2522917)
Pubblicazione: (2025)

Table 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
di: Xiangjun Wang (2522917)
Pubblicazione: (2025)

Image 3_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.jpeg
di: Xi Chen (35903)
Pubblicazione: (2025)

Table 2_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.docx
di: Xi Chen (35903)
Pubblicazione: (2025)

Table 1_Pan-cancer multi-omics characterization of calcyphosine and its revealed links to the immune microenvironment and regulatory networks in endometrial carcinoma.xlsx
di: Xi Chen (35903)
Pubblicazione: (2025)

Cannot write session to /tmp/vufind_sessions/sess_3qp19bpcsrejgcekh12ie35amf